Home  »  Company   »  Vallon Pharmaceuticals Inc.’s (NASDAQ: VLON) Sto...

Vallon Pharmaceuticals Inc.’s (NASDAQ: VLON) Stock Rises 21.58 Percent, But Further Upside Could Be On The Way

Vallon Pharmaceuticals Inc. (NASDAQ:VLON)’s traded shares stood at 1.94 million during the last session. At the close of trading, the stock’s price was $0.48, to imply an increase of 21.58% or $0.09 in intraday trading. The VLON share’s 52-week high remains $7.77, putting it -1518.75% down since that peak but still an impressive 56.25% since price per share fell to its 52-week low of $0.21. The company has a valuation of $6.66M, with an average of 1.22 million shares in intraday trading volume over the past 10 days and average of 7.35 million shares over the past 3 months.

Analysts have given a consensus recommendation of a Buy for Vallon Pharmaceuticals Inc. (VLON), translating to a mean rating of 2.00. Of 1 analyst(s) looking at the stock, 0 analyst(s) give VLON a Sell rating. 0 of those analysts rate the stock as Overweight while 0 advise Hold as 1 recommend it as a Buy. 0 analyst(s) have given it an Underweight rating. Estimates put the company’s current-quarter earnings per share at $0.

Do You Know The Best Place To Find Gains In Volatile Markets?

In today's chaotic marketplace, the biggest gains will come from some currently-small companies that pass by older, larger businesses still stuck in a pre-pandemic world. The trick is figuring out which small caps will be tomorrow's winners. That's why StockWire News has put together a special Wealth Building Report, highlighting 3 small cap stocks set to soar in 2023.

Click here for full details and to join for free.


Vallon Pharmaceuticals Inc. (NASDAQ:VLON) trade information

After registering a 21.58% upside in the last session, Vallon Pharmaceuticals Inc. (VLON) has traded red over the past five days. The stock hit a weekly high of 0.5200 this Thursday, 03/16/23, jumping 21.58% in its intraday price action. The 5-day price performance for the stock is 10.52%, and -26.17% over 30 days. With these gigs, the year-to-date price performance is 65.52%. Short interest in Vallon Pharmaceuticals Inc. (NASDAQ:VLON) saw shorts transact 0.32 million shares and set a 0.05 days time to cover.

Analysts on Wall Street suggest a consensus price target of $12.00, implying an increase of 96.0% to the stock’s current value. The extremes give us $12.00 and $12.00 for target low and target high price respectively. As such, VLON has been trading -2400.0% off suggested target high and -2400.0% from its likely low.

Vallon Pharmaceuticals Inc. (VLON) estimates and forecasts

VLON Dividends

Vallon Pharmaceuticals Inc. has its next earnings report out between May 08 and May 12. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too. Vallon Pharmaceuticals Inc. has a forward dividend ratio of 0, with the share yield ticking at 0.00% to continue the rising pattern observed over the past year. The company’s average dividend yield trailing the past 5-year period is 0.00%.

Vallon Pharmaceuticals Inc. (NASDAQ:VLON)’s Major holders

Vallon Pharmaceuticals Inc. insiders hold 30.52% of total outstanding shares, with institutional holders owning 13.92% of the shares at 20.04% float percentage. In total, 13.92% institutions holds shares in the company, led by Virtu Financial LLC. As of Sep 29, 2022, the company held over 0.13 million shares (or 1.02% of shares), all amounting to roughly $37157.0.

The next major institution holding the largest number of shares is Susquehanna International Group, LLP with 48644.0 shares, or about 0.38% of shares outstanding. As of the market price on Sep 29, 2022, these shares were worth $13878.0.

We also have Vanguard Extended Market Index Fund and Fidelity NASDAQ Composite Index Fund as the top two Mutual Funds with the largest holdings of the Vallon Pharmaceuticals Inc. (VLON) shares. Going by data provided on Sep 29, 2022, Vanguard Extended Market Index Fund holds roughly 22146.0 shares. This is just over 0.17% of the total shares, with a market valuation of $6318.0. Data from the same date shows that the other fund manager holds a little less at 9542.0, or 0.07% of the shares, all valued at about 2355.0.

Leave a Comment

Your email address will not be published. Required fields are marked *

On Key

Related Posts